GLP‑1 receptor agonist protects palmitate-induced insulin resistance in skeletal muscle cells by up-regulating sestrin2 to promote autophagy
Abstract In this study, we aimed to determine whether liraglutide could effectively reduce insulin resistance (IR) by regulating Sestrin2 (SESN2) expression in L6 rat skeletal muscle cells by examining its interactions with SESN2, autophagy, and IR. L6 cells were incubated with liraglutide (10–1000 ...
Main Authors: | Xue Tian, Yu Gao, Mowei Kong, Lihua Zhao, Enhong Xing, Qitian Sun, Jianqiu He, Yanan Lu, Zengbin Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-36602-6 |
Similar Items
-
The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus
by: Xue Tian, et al.
Published: (2022-06-01) -
Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy
by: Takafumi Osaka, et al.
Published: (2023-04-01) -
Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
by: Miguel Sánchez-Álvarez, et al.
Published: (2019-09-01) -
Ameliorative effects of polyunsaturated fatty acids against palmitic acid-induced insulin resistance in L6 skeletal muscle cells
by: Sawada Keisuke, et al.
Published: (2012-03-01) -
GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023-01-01)